240 related articles for article (PubMed ID: 32356145)
21. A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.
Walter TJ; Navarro M; Thiele TE; Pedersen C; Kampov-Polevoy A; Garbutt JC
Alcohol Alcohol; 2020 Feb; 55(1):56-62. PubMed ID: 31746964
[TBL] [Abstract][Full Text] [Related]
22. Early improvement in food cravings are associated with long-term weight loss success in a large clinical sample.
Dalton M; Finlayson G; Walsh B; Halseth AE; Duarte C; Blundell JE
Int J Obes (Lond); 2017 Aug; 41(8):1232-1236. PubMed ID: 28373674
[TBL] [Abstract][Full Text] [Related]
23. Recorded food intake of obese women with binge eating disorder before and after weight loss.
Yanovski SZ; Sebring NG
Int J Eat Disord; 1994 Mar; 15(2):135-50. PubMed ID: 8173559
[TBL] [Abstract][Full Text] [Related]
24. Mindfulness trait, eating behaviours and body uneasiness: a case-control study of binge eating disorder.
Compare A; Callus E; Grossi E
Eat Weight Disord; 2012 Dec; 17(4):e244-51. PubMed ID: 23047298
[TBL] [Abstract][Full Text] [Related]
25. Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion.
Halseth A; Shan K; Gilder K; Malone M; Acevedo L; Fujioka K
Obes Sci Pract; 2018 Apr; 4(2):141-152. PubMed ID: 29670752
[TBL] [Abstract][Full Text] [Related]
26. The Opioid System and Food Intake: Use of Opiate Antagonists in Treatment of Binge Eating Disorder and Abnormal Eating Behavior.
Valbrun LP; Zvonarev V
J Clin Med Res; 2020 Feb; 12(2):41-63. PubMed ID: 32095174
[TBL] [Abstract][Full Text] [Related]
27. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
Palavras MA; Hay P; Touyz S; Sainsbury A; da Luz F; Swinbourne J; Estella NM; Claudino A
Trials; 2015 Dec; 16():578. PubMed ID: 26683478
[TBL] [Abstract][Full Text] [Related]
28. Naltrexone/Bupropion extended release-induced weight loss is independent of nausea in subjects without diabetes.
Hong K; Herrmann K; Dybala C; Halseth AE; Lam H; Foreyt JP
Clin Obes; 2016 Oct; 6(5):305-12. PubMed ID: 27477337
[TBL] [Abstract][Full Text] [Related]
29. Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
Mason AE; Lustig RH; Brown RR; Acree M; Bacchetti P; Moran PJ; Dallman M; Laraia B; Adler N; Hecht FM; Daubenmier J; Epel ES
Appetite; 2015 Aug; 91():311-320. PubMed ID: 25931433
[TBL] [Abstract][Full Text] [Related]
30. Very-Low-Calorie Ketogenic Diet: A Potential Treatment for Binge Eating and Food Addiction Symptoms in Women. A Pilot Study.
Rostanzo E; Marchetti M; Casini I; Aloisi AM
Int J Environ Res Public Health; 2021 Dec; 18(23):. PubMed ID: 34886528
[TBL] [Abstract][Full Text] [Related]
31. The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy.
Fujioka K; Plodkowski R; O'Neil PM; Gilder K; Walsh B; Greenway FL
Int J Obes (Lond); 2016 Sep; 40(9):1369-75. PubMed ID: 27328752
[TBL] [Abstract][Full Text] [Related]
32. Symptoms of 'food addiction' in binge eating disorder using the Yale Food Addiction Scale version 2.0.
Carter JC; Van Wijk M; Rowsell M
Appetite; 2019 Feb; 133():362-369. PubMed ID: 30508614
[TBL] [Abstract][Full Text] [Related]
33. What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials.
Heal DJ; Gosden J
Int J Obes (Lond); 2022 Apr; 46(4):677-695. PubMed ID: 34992243
[TBL] [Abstract][Full Text] [Related]
34. Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression.
Segura-Garcia C; Rania M; Carbone EA; de Filippis R; Aloi M; Caroleo M; Grasso G; Calabrò G; Fazia G; Staltari FA; Falvo A; Pugliese V; Gaetano R; Steardo L; De Fazio P
Front Psychiatry; 2021; 12():635502. PubMed ID: 33815170
[No Abstract] [Full Text] [Related]
35. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes.
Hollander P; Gupta AK; Plodkowski R; Greenway F; Bays H; Burns C; Klassen P; Fujioka K;
Diabetes Care; 2013 Dec; 36(12):4022-9. PubMed ID: 24144653
[TBL] [Abstract][Full Text] [Related]
36. Naltrexone Reduces Binge Eating and Purging in Adolescents in an Eating Disorder Program.
Stancil SL; Adelman W; Dietz A; Abdel-Rahman S
J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):721-724. PubMed ID: 31313939
[No Abstract] [Full Text] [Related]
37. Binge Eating Disorder and Bipolar Spectrum disorders in obesity: Psychopathological and eating behaviors differences according to comorbidities.
Segura-Garcia C; Caroleo M; Rania M; Barbuto E; Sinopoli F; Aloi M; Arturi F; De Fazio P
J Affect Disord; 2017 Jan; 208():424-430. PubMed ID: 27846411
[TBL] [Abstract][Full Text] [Related]
38. [Triggers of bulimia and compulsion attacks: validation of the "Start" questionnaire].
Rigaud D; Jiang T; Pennacchio H; Brémont M; Perrin D
Encephale; 2014 Sep; 40(4):323-9. PubMed ID: 24091068
[TBL] [Abstract][Full Text] [Related]
39. New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists.
Barrea L; Pugliese G; Muscogiuri G; Laudisio D; Colao A; Savastano S
Minerva Endocrinol; 2020 Jun; 45(2):127-137. PubMed ID: 32643356
[TBL] [Abstract][Full Text] [Related]
40. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
